Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors
Lifeward announced the appointment of Robert J. Marshall Jr. to its Board of Directors, effective November 2, 2024. Mr. Marshall will serve as Chairman of the Audit Committee. He brings over 30 years of experience in financial management and strategy, mainly in the medical device industry. Currently, he is the CFO and Treasurer of Lantheus Holdings. His previous roles include senior leadership positions at Zimmer Biomet Holdings, where he managed finance for U.S., Canadian, and Latin American markets. Marshall expressed his enthusiasm for Lifeward's mission and future in rehabilitation advancements. Lifeward's Chairman, Joe Turk, highlighted Marshall's financial acumen and governance capabilities as significant assets to the Board.
Lifeward ha annunciato la nomina di Robert J. Marshall Jr. nel suo Consiglio di Amministrazione, a partire dal 2 novembre 2024. Il signor Marshall ricoprirà il ruolo di Presidente del Comitato di Revisione. Porta con sé oltre 30 anni di esperienza nella gestione finanziaria e nella strategia, principalmente nel settore dei dispositivi medici. Attualmente, è il CFO e Tesoriere di Lantheus Holdings. Le sue precedenti esperienze includono posizioni di leadership senior presso Zimmer Biomet Holdings, dove ha gestito le finanze per i mercati degli Stati Uniti, del Canada e dell'America Latina. Marshall ha espresso il suo entusiasmo per la missione di Lifeward e per il futuro dei progressi nella riabilitazione. Il Presidente di Lifeward, Joe Turk, ha sottolineato le competenze finanziarie e le capacità di governance di Marshall come asset significativi per il Consiglio.
Lifeward anunció el nombramiento de Robert J. Marshall Jr. en su Junta Directiva, con efecto a partir del 2 de noviembre de 2024. El Sr. Marshall se desempeñará como Presidente del Comité de Auditoría. Aporta más de 30 años de experiencia en gestión financiera y estrategia, principalmente en la industria de dispositivos médicos. Actualmente, es el CFO y Tesorero de Lantheus Holdings. Anteriormente, ocupó altos cargos de liderazgo en Zimmer Biomet Holdings, donde gestionó las finanzas para los mercados de EE.UU., Canadá y América Latina. Marshall expresó su entusiasmo por la misión de Lifeward y el futuro en los avances en rehabilitación. El presidente de Lifeward, Joe Turk, destacó el conocimiento financiero y las capacidades de gobernanza de Marshall como activos significativos para la Junta.
Lifeward는 Robert J. Marshall Jr.를 이사회에 임명했다고 발표했으며, 이는 2024년 11월 2일부터 효력이 발생합니다. Marshall 씨는 감사위원회의 의장으로 활동할 예정입니다. 그는 주로 의료 기기 산업에서 재무 관리 및 전략 분야에서 30년 이상의 경험을 쌓아왔습니다. 현재 그는 Lantheus Holdings의 CFO 및 재무 담당입니다. 이전에는 Zimmer Biomet Holdings에서 미국, 캐나다 및 라틴 아메리카 시장을 위한 재무를 관리하는 고위 리더십 직책을 역임했습니다. Marshall 씨는 Lifeward의 사명과 재활 발전의 미래에 대한 열정을 표명했습니다. Lifeward의 회장인 Joe Turk는 Marshall 씨의 재무 지식과 거버넌스 능력이 이사회의 중요한 자산이라고 강조했습니다.
Lifeward a annoncé la nomination de Robert J. Marshall Jr. à son conseil d'administration, effective à partir du 2 novembre 2024. M. Marshall siégera en tant que président du comité d'audit. Il apporte plus de 30 ans d'expérience en gestion financière et en stratégie, principalement dans l'industrie des dispositifs médicaux. Actuellement, il est CFO et trésorier de Lantheus Holdings. Ses précédents rôles incluent des postes de direction senior chez Zimmer Biomet Holdings, où il était responsable des finances pour les marchés des États-Unis, du Canada et d'Amérique latine. Marshall a exprimé son enthousiasme pour la mission de Lifeward et pour l'avenir des avancées en réhabilitation. Le président de Lifeward, Joe Turk, a souligné les compétences financières et les capacités de gouvernance de Marshall comme des atouts importants pour le conseil.
Lifeward gab die Ernennung von Robert J. Marshall Jr. in den Vorstand bekannt, die am 2. November 2024 in Kraft tritt. Herr Marshall wird als Vorsitzender des Prüfungsausschusses fungieren. Er bringt über 30 Jahre Erfahrung im Finanzmanagement und in der Strategie mit, hauptsächlich in der Medizintechnikbranche. Derzeit ist er CFO und Schatzmeister von Lantheus Holdings. Zuvor hatte er leitende Führungspositionen bei Zimmer Biomet Holdings inne, wo er die Finanzen für die Märkte in den USA, Kanada und Lateinamerika leitete. Marshall äußerte seine Begeisterung für die Mission von Lifeward und die Zukunft der Rehabilitationsfortschritte. Der Vorsitzende von Lifeward, Joe Turk, hob Marshalls finanzielle Fachkenntnisse und Governance-Fähigkeiten als bedeutende Vermögenswerte für den Vorstand hervor.
- Appointment of Robert J. Marshall Jr., a seasoned financial executive, to the Board of Directors.
- Marshall's role as Chairman of the Audit Committee strengthens financial oversight.
- Marshall's extensive experience in the medical device industry adds valuable insights.
- Marshall's current role as CFO and Treasurer of Lantheus Holdings enhances Lifeward's strategic financial management.
- None.
Financial executive brings over 30 years of experience and leadership in financial management and strategy
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions in physical rehabilitation and recovery, announced the Board of Directors has approved the appointment of Robert J. Marshall Jr. as a new director effective November 2, 2024. As part of his duties as a director, Mr. Marshall will serve as Chairman of the Audit Committee.
Mr. Marshall has had a long and accomplished finance career in the medical device industry. Currently, Mr. Marshall serves as the Chief Financial Officer and Treasurer of Lantheus Holdings, Inc., a publicly traded radiopharmaceutical company, where he has worked since September 2018. Prior to joining Lantheus, Mr. Marshall spent 16 years with Zimmer Biomet Holdings, Inc., a publicly traded global medical device company with a leading position in musculoskeletal health, in which he held various senior leadership roles, including Vice President, Investor Relations and Corporate Treasurer, and most recently Vice President, Americas Finance, for the U.S., Canadian and Latin American commercial markets. Before Zimmer Biomet, Mr. Marshall was employed with Brown & Williamson Tobacco, a subsidiary of British American Tobacco, p.l.c., in Louisville, Kentucky, where he held several positions of increasing responsibility.
“I am very attracted to the mission of Lifeward, and I believe the Company has a very promising future in driving advancements in the rehabilitation of individuals with physical and neurological disabilities and conditions,” said Mr. Marshall. “I look forward to contributing my financial knowledge and public markets experience to further Lifeward in its pursuit of its goals.”
“Lifeward is very pleased to add Bob to the team and he will have the opportunity to apply his considerable financial acumen and insights to the Board in its role of oversight and strategic guidance for Lifeward,” said Joe Turk, Chairman of the Board of Directors. “Bob will be a valuable addition to the governance capabilities of the Board.”
For more information, please visit GoLifeward.com
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the MyoCycle FES System, and the ReStore Exo-Suit.
Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward product portfolio, please visit GoLifeward.com.
Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Forward-looking statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding Lifeward's future performance and future regulatory interactions and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in the Company’s periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading "Risk Factors" in the Company’s annual report on Form 10-K and 10-K/A for the year ended December 31, 2023 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Lifeward Media Relations:
Kathleen O’Donnell
VP Marketing & New Business Development
Lifeward
E: media@golifeward.com
Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com
FAQ
Who has Lifeward appointed to its Board of Directors?
When did Robert J. Marshall Jr. join Lifeward's Board of Directors?
What role will Robert J. Marshall Jr. serve on Lifeward's Board?
What is Robert J. Marshall Jr.'s current position?
What experience does Robert J. Marshall Jr. bring to Lifeward?
